Generic drugmaker Mylan has announced a plan to invest €380 million in its operations in the Republic of Ireland, including …
Trio become latest Symbiosis commercial additions
UK immunoglobulin supply faces growing pressure, report warns
How will biomarker-led diagnostics reshape respiratory medicine?

